Catalyst Wire Dossier Catalyst Wire Dossier

IONIS-GHR-LRx

· Ionis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IONIS-GHR-LRx, covering 2022-11-14 to 2024-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly [Phase 2]

See pricing